Latest News
Core facilities, learning opportunities available for researchers, staff
The UNC School of Medicine Office of Research Technologies is fostering an environment of community and mentoring for UNC core directors and researchers at the UNC School of Medicine and across campus.
Three SOM faculty named TBJ Health Care Heroes
At the annual Triangle Business Journal Health Care Heroes awards dinner, three UNC School of Medicine faculty were honored, as well as four other UNC Health Care employees.
A few minutes with Stephen Frye, PhD
After a 20-year career in the pharmaceutical industry, Stephen Frye, PhD, joined the UNC faculty in 2007 with the goal of partnering with physician-scientists to develop new cancer therapeutics. In May, he and his wife Susan will ride 60 miles on a tandem bicycle to support Team UNC Lineberger in The Victory Ride to Cure Cancer. We recently sat down with Frye to talk about his love of chemistry, his interest in writing, and his desire to break the 50 mph barrier on his bicycle.
Wake Forest Baptist, UNC Health Care Sign Binding Definitive Agreement Regarding Ownership of High Point Regional Health
Over the coming months, leadership from both Wake Forest Baptist and High Point Regional Health will be working together to take the necessary steps toward full integration.
The Problem of Burnout Among Surgeons
UNC School of Medicine's Marco Patti, MD, is the senior author of an article on burnout in JAMA Surgery.
UNC School of Medicine Announces three new Sarah Graham Kenan Distinguished Professors
Three exemplary physician-scientists at the UNC School of Medicine – David Margolis, MD, Ada Adimora, MD, MPH, and Janet Rubin, MD – have been named Sarah Graham Kenan Distinguished Professors.
Goldman to step down as chair of the department of microbiology and immunology
The UNC School of Medicine is conducting a national search to fill the position of department chair.
To halt breast cancer’s spread, scientists block amino acid found in asparagus
UNC Lineberger researchers Charles M. Perou, PhD, and Lisa A. Carey, MD, were part of a preclinical study led out of the Cancer Research UK Cambridge Institute that found that blocking the production of asparagine with a drug called L-asparaginase in mice with aggressive triple negative breast tumors, and putting them on a low-asparagine diet, reduced the breast tumor’s ability to spread.
UNC Researcher Helps Find Solutions for Childcare Conundrum at Academic Conferences
Paola Giusti-Rodriguez, PhD, is one of 40 scientists that contributed to a paper outlining the difficulties parents encounter when attending conferences. They offer solutions that could quickly improve attendance and involvement of mothers at these events.
Calcium supplements may increase the risk of bowel lesions
Possible risks must be weighed against the benefits of supplements, a study led by Seth Crockett, MD, MPH, finds.
Hayes-Jordan named Chief, Division of Pediatric Surgery, Surgeon in Chief, North Carolina Children’s Hospital
Andrea Hayes-Jordan, MD, FACS, FAAP, a pioneering surgeon and researcher, has been named Chief of the Division of Pediatric Surgery at the UNC School of Medicine, and Surgeon in Chief at the North Carolina Children’s Hospital. She will officially join the UNC School of Medicine faculty effective June 1, 2018.
Prognostic tool could identify high-risk breast cancer patients
In the journal Cell Chemical Biology, researchers led by UNC Lineberger's Xian Chen, PhD, report on potential prognostic tool that could be used to identify high-risk patients within particular subtypes of breast cancer.
Earp named Director of UNC Lineberger
Shelton Earp, MD, has been named director of the UNC Lineberger Comprehensive Cancer Center. Earp has served as interim director since June 2017, a role he accepted after Norman E. “Ned” Sharpless, MD, UNC Lineberger’s director since January 2014, was nominated to become the director of the National Cancer Institute.
Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it
A team led by UNC Lineberger's Gianpietro Dotti, MD, has engineered immune cells to hunt glioblastoma, the most lethal primary brain tumor.
Narratives That Are Shared: Writing for Resilience
For five years, Writing for Resilience has met most Tuesdays, offering a place for caregivers, patients, providers and the community at large a place to quietly reflect, and the chance to discover what shifts in perspective might sneak up on them while they put pen to paper.
UNC to Host Brain Stimulation Conference
Spearheaded by Flavio Frohlich, PhD, the conference will gather the top minds in the field of neurostimulation this May in Chapel Hill. Registration is now open.
Vote for UNC SOM research during STAT Madness 2018!
STAT magazine's annual March Madness biomedical research competition is in the round of 32. Find the UNC School of Medicine Logo and vote for Bryan Roth's research on the science of LSD.
Phase I clinical trial shows promise as investigational drug for melanoma
Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.
Blue Cross Blue Shield invests $1.2 million to support UNC School of Medicine Physician Assistant Studies Program
Blue Cross NC announced continued investment in the two-year Physician Assistant Studies program, led by Paul Chelminski and housed in the Department of Allied Health Sciences.
Peanut allergy therapy proves effective during phase 3 clinical trial
Wesley Burks, MD, was a principal investigator on the phase 3 PALISADE trial to determine the efficacy of the AR101 oral immunotherapy developed by Aimmune Therapeutics for people allergic to peanuts.